Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 35 member B1 (SLC35B1) is a membrane transporter protein localized to the endoplasmic reticulum (ER) that mediates the strict exchange of ATP and ADP across the ER membrane. SLC35B1 is essential for maintaining an intraluminal supply of ATP, fueling protein folding, quality control, and trafficking within the ER. The protein operates by a distinctive antiport mechanism, exchanging cytosolic ATP for luminal ADP, and its function is structurally distinct from canonical nucleotide sugar transporters; it does not bind nucleotide sugars but specifically mediates ATP/ADP exchange. SLC35B1 is evolutionarily conserved, and loss of its function leads to decreased ER ATP levels, impaired chaperone activity (e.g., reduced BiP function), and reduced cell growth, underscoring its fundamental role in cell biology. Dysregulation or dysfunction of SLC35B1 has been implicated or suggested in diseases involving ER stress, such as type 2 diabetes, cancer, and neurodegenerative disorders. Current research aims to identify small molecules that modulate SLC35B1 activity, which could offer new avenues for therapeutic intervention in ER stress-related diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member B1 (SLC35B1).